Drug delivery properties of macroporous polystyrene solid foams

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 15, Issue 1, 2012, Pages 197-207

  Canal, C ^a,c,d   Aparicio, R M ^a,c   Vilchez A ^b,c   Esquena, J ^b,c   Garcia Celma M J ^a,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

^c BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^d UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIVINYLBENZENE; KETOPROFEN; POLYSTYRENE; POROUS POLYMER;

ARTICLE; CONCENTRATION (PARAMETERS); DELAYED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSAGE FORM; DRUG STRUCTURE; EMULSION; HYDROPHOBICITY; LIPOPHILICITY; POLYMERIZATION; POROSITY; SURFACE PROPERTY;

EID: 84857683289     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3x884     Document Type: Article

References (48)

1. nd Ed. Aulton ME. Ed. Churchill Livingstone, Elsevier, 2002.
2. Arzhavitina A., Steckel H. Foams for pharmaceutical and cosmetic application International Journal of Pharmaceutics 394: 1-17, 2010.
3. Perut F, Montufar EB, Ciapetti G, Santin M, Salvage J, Traykova T, Planell JA, Ginebra MP, Baldini N. Novel soybean/gelatine-based bioactive and injectable hydroxyapatite foam: Material properties and cell response, Acta Biomaterialia 7:1780-1787, 2011.
4. O'Brien FJ, Harley BA, Waller MA, Yannas IV, Gibson LJ, Prendergast PJ. The effect of pore size on permeability and cell attachment in collagen scaffolds for tissue engineering. Technol Health Care 15(1):3-17, 2007.
5. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26:5474-91, 2005.
6. Raucci MG, D'Antǒ V, Guarino V, Sardella E, Zeppetelli S, Favia P, et al. Biomineralized porous composite scaffolds prepared by chemical synthesis for bone tissue regeneration. Acta Biomater 6:4090-9, 2010.
7. Kim HW, Knowles JC, Kim HE. Hydroxyapatite/poly([epsilon]-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. Biomaterials 25:1279-87, 2004.
8. Hedberg EL, Shih CK, Lemoine JJ, Timmer MD, Liebschner MAK, Jansen JA. In vitro degradation of porous poly(propylene fumarate)/poly(DL-lactic-coglycolic acid) composite scaffolds. Biomaterials 26:3215-25, 2005.
9. Pek YS, Gao S, Mohamed Arshad MS, Leck K-J, Ying JY. Porous collagen-apatite nanocomposite foams as bone regeneration scaffolds. Biomaterials 29:4300-4305, 2008.
10. Diamond NG, Casarella WJ, Bachman DM, Wolff M. Microfibrillar collagen hemostat: a new transcatheter embolization agent. Radiology 133:775-779, 1979.
11. Yannas IV, Burke JF, Warpehoski M, Stasikelis P, Skrabut EM, Orgill D, Giard DJ. Prompt, long-term functional replacement of skin. Trans Am Soc Artif Intern Organs 27:19-22, 1981.
12. Doillon CJ, Silver FH, Berg RA. Fibroblast growth on a porous collagen sponge containing hyaluronic acid and fibronectin. Biomaterials 8:195-200, 1987.
13. Grenga T, Zins JE, Bauer TW. The rate of vascularization of coralline hydroxyapatite. Plas. Reconstr. Surg. 84:245-249, 1989.
14. Liao SS, Cui FZ, Zhang W, Feng QL. Hierarchically biomimetic bone scaffold materials: nano-HA/collagen/PLA composite. J Biomed Mater Res 69B:158-165, 2004.
15. Schliephake H, Neukam FW, Klosa D. Influence of pore dimensions on bone ingrowth into porous hydroxyapatite blocks used as bone substitutes. A histometric study. J Oral Maxillofac Surg 20:53-58, 1991.
16. Tancred DC, McCormack BAO, Carr AJ. A synthetic bone implant macroscopically identical to cancellous bone. Biomaterials 19:2303-2311, 1998.
17. Sher P, Ingavle G, Ponrathnam S, Pawar AP. Low density porous carrier based conceptual drug delivery system. Microp. Mesop. Mat., 102:290-298, 2007.
18. Sant S, Nadeau V, Hildgen P. Effect of porosity on the release kinetics of propafenone-loaded PEG-g-PLA nanoparticles. J. Control Release, 107:203-214, 2005.
19. Hartmann M. Ordered Mesoporous Materials for Bioadsorption and Biocatalysis, Chem. Mater., 17:4577-4593, 2005.
20. Yiu HHP, Wright PA. Enzymes supported on ordered mesoporous solids: a special case of an inorganic-organic hybrid. J. Mater. Chem., 15:3690-3700, 2005.
21. Wang S. Ordered mesoporous materials for drug delivery. Microporous and Mesoporous Mat., 117:1-9, 2009.
22. Song SW, Hidajat K, Kawi S. Functionalized SBA-15 Materials as Carriers for Controlled Drug Delivery: Influence of Surface Properties on Matrix- Drug Interactions. Langmuir, 21:9568-9575, 2005.
23. Ruckenstein E. Concentrated emulsion polymerization. Adv. Polym. Sci., 127:1-58, 1997.
24. Ciesla U, Schüth F. Ordered mesoporous materials. Microp. Mesop. Mat., 27(2-3):131-149, 1999.
25. Esquena J, Sankar GSRR, Solans C. Highly concentrated W/O emulsions prepared by the PIT method as templates for solid foams. Langmuir, 19:2983-2988, 2003.
26. Kaemmerlen A, Vo C, Asllanaj F, Jeandel G, Baillis D. Radiative properties of extruded polystyrene foams: Predictive model and experimental results J. Quantitative Spectroscopy & Radiative Transfer 111: 865-877, 2010.
27. J.R. Memon JR, Pathan AG. Efficiency of Cd(II) removal from aqueous media by using chemically modified polystyrene foam. European Polymer J. 44: 1501-1511, 2008.
28. Esquena J, Solans C., Highly Concentrated Emulsions as Templates for Solid Foams, in: J. Sjöblom, ed. Emulsions and Emulsion Stability. New York: Taylor and Francis, 2006.
29. Williams JM, Wrobleski DA. Spatial distribution of the phases in water-in-oil emulsions. Open and closed microcellular foams from cross-linked polystyrene. Langmuir, 4: 4062-4067, 1988.
30. Barby D, Haq Z. Eur. Patent 0060138, 1982.
31. Kunieda H, Shinoda K. Evaluation of the hydrophile-lipophile balance (HLB) of nonionic surfactants. I. Multisurfactant systems. J. Colloid Interface Sci., 107:107-121, 1985.
32. Kunieda H, Fukui Y, Uchiyama H, Solans C. Spontaneous formation of highly concentrated water-in-oil emulsions (gel-emulsions). Langmuir 12: 2136-2140, 1996.
33. Ozawa K, Solans C, Kunieda H. Spontaneous formation of Highly Concentrated Water-in-oil emulsions. J. Colloid Interface Sci. 188:275-281, 1997.
34. Solans C, Pons R, Kunieda H. In Modern Aspects of Emulsion Science; Binks BP Ed. Royal Society of Chemistry: Cambridge, U.K., 367-394, 1998.
35. Ensing GT. Prevention and treatment of biomaterial related infection in orthopedics: a study of application of ultrasound and of antibiotic release. PhD Thesis, Rijksuniversiteit Groningen 2006.
36. Yoon JJ, Kim JH, Park TG. Dexamethasone releasing biodegradable polymer scaffolds fabricated by a gas foaming/salt leaching method. Biomaterials, 24:2323-2329, 2003.
37. Chen J, Wang C, Lu S, Wu J, Guo X, Duan C, Dong L, Song Y, Zhang J, Jing D, Wu L, Ding J, Li D. In vivo chondrogenesis of adult bone-marrow-derived autologous mesenchymal stem cells. Cell Tissue Res., 319:429-438, 2005.
38. Kantor TG. Ketoprofen: a review of its pharmacologic and clinical properties. Pharmacotherapy, 6(3): 93-103, 1986.
39. Brunauer S, Emmett PH, Teller E. Adsorption of gases in multimolecular layers J. Am. Chem. Soc. 60: 309-315, 1938.
40. Barret EP, Joyner JG, Halenda PP. The determination of pore volume and Area distributions in porous substances I. Computations from Nitrogen Isotherms J. Am. Chem. Soc. 73: 373-380, 1951.
41. Calderó G, García-Celma MJ, Solans C, Plaza M, Pons R, Influence of Composition Variables on the Molecular Diffusion from Highly Concentrated Water-in-Oil Emulsions (Gel-Emulsions). Langmuir, 13:385-390, 1997.
42. Canal C, Gaboriau F, Vílchez A, Erra P, García-Celma MJ, Esquena J. Topographical and Wettability Effects of Post-Discharge Plasma Treatments on Macroporous Polystyrene-Divinylbenzene Solid Foams. Plasma Process. Polym,6(10):686-692, 2009.
43. Molina R, Vílchez A, Canal C, Esquena J. Wetting properties of polystyrene/divinylbenzene crosslinked porous polymers obtained using W/O highly concentrated emulsions as templates. Surf. Interface Anal., 41(5):371-377, 2009.
44. Esquena J, Rodriguez C, Solans C, Kunieda H, Formation of mesostructured silica in nonionic fluorinated surfactant systems, Microp. Mesop. Mater., 92:212-219, 2006.
45. Cassie ABD, Baxter S. Wettability of porous surfaces. Trans. Faraday Soc., 40:546-551, 1944.
46. Quéré D. Fakir Droplets. Nat. Mater., 1:14-15, 2002.
47. Lee LY., Ranganath SH, Fu Y, Zheng JL, Lee HS, Wang C-H, Smith KA. Paclitaxel release from micro-porous PLGA disks. Chemical Engineering Science 64: 4341-4349, 2009.
48. Lao LL, Peppas NA, Boey FYC, Venkatraman SS. Modeling of drug release from bulk-degrading polymers International Journal of Pharmaceutics 418: 28-41, 2011.